25 Stocks Moving In Friday's Pre-Market Session

Gainers

• Skechers USA Inc SKX rose 26.4 percent to $30.36 in pre-market trading as the company reported better-than-expected results for its third quarter on Thursday.
• Uniqure NV QURE rose 15.1 percent to $17.45 in pre-market trading. Uniqure shares climbed 60.08 percent Thursday as the company disclosed that it has acquired a patent family providing broad protection of the hyperactive padua variant of Factor IX.
• Atlassian Corporation PLC TEAM shares rose 12.1 percent to $45.10 in pre-market trading after the company reported first-quarter sales growth of 42 percent year over year.
• Digital Ally, Inc. DGLY shares rose 9.1 percent to $2.40 in pre-market trading. Digital Ally and VIEVU, LLC entered into a supply agreement which provides VIEVU exclusive right to integrate the VuLInk system in its body camera products.
• RedHill Biopharma Ltd - ADR RDHL shares rose 8.4 percent to $9.52 in the pre-market trading session after the company disclosed that it has received the FDA Orphan Drug designation for MESUPRON for pancreatic cancer.
• Immune Design Corp IMDZ rose 8.2 percent to $5.95 in pre-market trading after the company confirmed the receipt of Orphan Drug Designation from the European Medicines Agency for G100.
• Kalvista Pharmaceuticals Inc KALV shares rose 7.9 percent to $10.00 in pre-market trading. KalVista Pharmaceuticals Director Aldrich bought 565,065 shares at an average price of $8.61.
• Veritone Inc VERI shares rose 6.9 percent to $36.75 in pre-market trading after dropping 8.69 percent on Thursday.
• Transenterix Inc TRXC rose 6.5 percent to $3.28 in pre-market trading after tumbling 15.62 percent on Thursday.
• Telefonaktiebolaget LM Ericsson ERIC rose 6.1 percent to $6.26 in the pre-market trading session after the company reported Q3 results.
• Helios and Matheson Analytics Inc HMNY rose 5.8 percent to $17.05 in pre-market trading after dropping 1.29 percent on Thursday.
• Dean Foods Co DF rose 4.5 percent to $10.85 in pre-market trading after falling 0.95 percent on Thursday.
• Viking Therapeutics Inc VKTX rose 4.4 percent to $3.11 after jumping 14.62 percent on Thursday.
• Paypal Holdings Inc PYPL rose 3.6 percent to $69.69 in pre-market trading after the company reported stronger-than-expected results for its third quarter on Thursday.
• Synchrony Financial SYF shares rose 3.2 percent to $32.70 in pre-market trading after reporting upbeat quarterly results.
• Lululemon Athletica inc. LULU shares rose 2.5 percent to $61.50 in the pre-market trading session. Citigroup upgraded Lululemon from Neutral to Buy.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Axon Enterprise Inc AAXN fell 12.7 percent to $21.50 in pre-market trading after the company disclosed that it became aware of the SEC comment letter. Axon said due to miscommunication issues, the company only became aware of letters today and is in the process of providing SEC with info to respond to its comments.
• Celgene Corporation CELG fell 5.6 percent to $128.32 in pre-market trading after the company announced it would cancel two trials for its drug for an inflammatory bowel disease. Citigroup downgraded Celgene from Buy to Neutral.
• General Electric Company GE shares fell 4.8 percent to $22.45 in pre-market trading after the company reported weaker-than-expected earnings for its third quarter and lowered its FY17 earnings outlook.
• Roku Inc ROKU fell 4.5 percent to $21.03 in pre-market trading after declining 0.09 percent on Thursday.
• Intuitive Surgical, Inc. ISRG shares fell 4.1 percent to $343.00 in pre-market trading. Intuitive Surgical posted upbeat earnings for its third quarter on Thursday.
• Diebold Nixdorf Inc DBD shares fell 3 percent to $21.40 in pre-market trading. Diebold Nixdorf is expected to release Q3 financial results on October 31.
• Plug Power Inc PLUG shares fell 2.8 percent to $2.46 in pre-market trading after declining 0.78 percent on Thursday.
• Qudian Inc - ADR QD shares fell 2.6 percent to $34.01 in pre-market trading after gaining 19.60 percent on Thursday.
• Regeneron Pharmaceuticals Inc REGN fell 2.3 percent to $430.77 in the pre-market trading session. Barclays downgraded Regeneron Pharmaceuticals from Equal-Weight to Underweight.